Literature DB >> 19910295

Intravenous and oral sulodexide versus coagulation activation markers in humans.

Jacek Borawski, Miroslaw Dubowski, Alicja Rydzewska-Rosolowska, Michal Mysliwiec.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19910295     DOI： 10.1177/1076029609333674

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN： 1076-0296            Impact factor:   2.389


× No keyword cloud information.
  3 in total

1.  Effect of sulodexide in patients with non-proliferative diabetic retinopathy: diabetic retinopathy sulodexide study (DRESS).

Authors:  Ji Hun Song; Hee Seung Chin; Oh Woong Kwon; Su Jin Lim; Ha Kyoung Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-12       Impact factor: 3.117

Review 2.  Development and use of sulodexide in vascular diseases: implications for treatment.

Authors:  Sergio Coccheri; Ferdinando Mannello
Journal:  Drug Des Devel Ther       Date:  2013-12-24       Impact factor: 4.162

3.  Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Giuseppe M Andreozzi; Angelo A Bignamini; Giovanni Davì; Gualtiero Palareti; Jiří Matuška; Martin Holý; Katarzyna Pawlaczyk-Gabriel; Andrej Džupina; German Y Sokurenko; Yury P Didenko; Laurentia D Andrei; Gianfranco Lessiani; Adriana Visonà
Journal:  Circulation       Date:  2015-09-25       Impact factor: 29.690
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.